The variation in gene expression profiles between IDH-mutant astrocytomas and oligodendrogliomas is primarily influenced by the tumor microenvironment and specific genetic mutations, rather than by distinct glial lineages. The gene discussed is IDH2; the disease is oligodendroglioma.